Target intelligence / Profile preview

Salmonella enterica serovar Typhi Vi Capsular Polysaccharide Antigen (Vi antigen)

Target
Vi antigen
Molecular classification
Polysaccharide, Capsular Polysaccharide, Antigen
01

Overview

The Vi capsular polysaccharide antigen is a surface-expressed linear polysaccharide unique to Salmonella enterica serovar Typhi, the causative agent of typhoid fever. It is a major virulence factor, enabling S. Typhi to evade innate immune responses by inhibiting phagocytosis and reducing complement deposition. It is also an important target for vaccine development; purified Vi antigen is used as a standalone vaccine with moderate efficacy in adults, while conjugation to carrier proteins converts it into a highly effective vaccine across all age groups.

Other names
Vi capsular polysaccharideVi polysaccharideVi antigen
02

Mechanism of action

Antibody-mediated neutralization, complement activation, monocyte phagocytosis

03

Biological functions

Immune evasionInhibition of phagocytosisReduction of complement depositionModulation of proinflammatory signaling
04

Disease associations

Typhoid feverInfection
05

Safety considerations

Limited efficacy of standalone Vi vaccinePoor efficacy in children under two years old for standalone Vi vaccine
06

Interacting drugs

Vi polysaccharide vaccine

1 more in the full profile.

07

Biomarkers

Anti-Vi IgG antibodies

Beyond the preview

Go deeper on Salmonella enterica serovar Typhi Vi Capsular Polysaccharide Antigen (Vi antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella enterica serovar Typhi Vi Capsular Polysaccharide Antigen (Vi antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call